
A China regulatory watchdog group has turned its focus to its insurance technology platforms as the banking and insurance watchdog continues its crack down on businesses in several vertical markets, reported PYMNTS.
The regulatory group’s latest order says insurance companies and local agencies must stop improper marketing and pricing practices and strengthen user privacy protection. Companies must address these issues or face “severe punishment,” according to a report.
Online insurance had been expected to grow into a 2.5 trillion yuan ($385 billion) industry within the next 10 years, according to Bloomberg. By the end of 2020, more than 140 Chinese insurance companies had launched online businesses, with total premiums of 298 billion yuan ($45 billion) for the year, a China Banking and Insurance Regulatory Commission (CBIRC) official said in a May speech.
Private equity and venture capital companies are redirecting their strategies from tech industries that are subject to intense scrutiny and sudden changes in regulations, according to a Reuters report on Monday (Aug. 9).
A recent wave of crackdowns by various Chinese agencies, starting with the halting of Ant Group’s IPO, triggered new laws, big fines and plenty of uncertainty and fear.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Trump Administration Steps Up Pressure On EU Digital Laws
May 18, 2025 by
CPI
Elton John Slams UK Government’s AI Copyright Plan as ‘Theft’
May 18, 2025 by
CPI
Anthropic’s Legal Team Blames AI “Hallucination” for Citation Error in Copyright Lawsuit
May 18, 2025 by
CPI
Intel Challenges €376 Million EU Antitrust Fine in Ongoing Legal Battle
May 18, 2025 by
CPI
FTC Chairman Highlights Fiscal Responsibility and Consumer Protection in House Testimony
May 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas